Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
1.
J Hosp Infect ; 144: 14-19, 2024 Feb.
Article in English | MEDLINE | ID: mdl-38092304

ABSTRACT

BACKGROUND: Antibiotic stewardship (AS) interventions in paediatrics are still not standardized regarding methodology, metrics, and outcomes. We report the results of an AS intervention in the paediatric area based on education and guideline provision via an electronic App. MATERIALS AND METHODS: The AS intervention was conducted in 2021 through observation, education, audit and feedback and provision of an electronic App (Firstline.org) to support antibiotic prescription based on local susceptibility data. The primary outcome was the antibiotic consumption in the 12 months following the intervention (year 2022) compared with a historical 12-month control (year 2019) via an interrupted time series analysis. Secondary outcomes were appropriateness of therapy, length of stay, 30-day readmission, transfers to the paediatric intensive care unit, in-hospital mortality, and prevalence of antimicrobial resistance (AMR). RESULTS: During the post-intervention phase, 29 cross-sectional audits and feedback were conducted including 467 patients. Prescriptions were appropriate according to the guidelines in 85.7% of cases, with a stable trend over time. A significant decrease in antibiotic consumption was measured in terms of defined daily doses per 1000 patient days (-222.13; P<0.001) and days of therapy per 1000 patient days (-452.49; P<0.001) in the post-intervention period with a clear inversion of the Access to Watch ratio (from 0.7 to 1.7). Length of stay, in-hospital mortality, intensive care unit transfers, and incidence of AMR infections remained stable, while 30-day readmission decreased from 4.9 per 100 admissions to 2.8 per 100 admissions (P<0.001). CONCLUSIONS: The intervention was associated with a significant reduction in antimicrobial consumption and an increase in the appropriateness of prescriptions. Electronic tools can be of value in promoting adherence to guidelines and ensuring the sustainability of results.


Subject(s)
Anti-Bacterial Agents , Anti-Infective Agents , Humans , Child , Anti-Bacterial Agents/therapeutic use , Cross-Sectional Studies , Length of Stay , Drug Resistance, Bacterial , Anti-Infective Agents/therapeutic use , Intensive Care Units, Pediatric
2.
Allergol. immunopatol ; 46(1): 99-104, ene.-feb. 2018. tab
Article in English | IBECS | ID: ibc-170793

ABSTRACT

Nowadays, the awareness of risks related to infectious diseases has decreased, whereas THE perception of risks related to vaccination is growing. Therefore, it may be difficult for health care providers to convince people of the importance of vaccination and adherence to the immunisation schedule. Selected situations that might raise uncertainties about vaccine recommendations are discussed in order to help health care providers to identify real and perceived contraindications to vaccines, and cases to be referred to specialised pre-vaccination consultation due to an increased risk of adverse events to vaccines (AU)


No disponible


Subject(s)
Humans , Vaccines/adverse effects , Drug-Related Side Effects and Adverse Reactions/epidemiology , Vaccination , Communicable Disease Control/trends , Risk Factors , Practice Patterns, Physicians' , Drug Hypersensitivity/epidemiology
3.
Allergol Immunopathol (Madr) ; 46(1): 99-104, 2018.
Article in English | MEDLINE | ID: mdl-28495398

ABSTRACT

Nowadays, the awareness of risks related to infectious diseases has decreased, whereas THE perception of risks related to vaccination is growing. Therefore, it may be difficult for health care providers to convince people of the importance of vaccination and adherence to the immunisation schedule. Selected situations that might raise uncertainties about vaccine recommendations are discussed in order to help health care providers to identify real and perceived contraindications to vaccines, and cases to be referred to specialised pre-vaccination consultation due to an increased risk of adverse events to vaccines.


Subject(s)
Anaphylaxis/immunology , Contraindications , Infections/immunology , Vaccination , Vaccines/immunology , Child , Clinical Decision-Making , Health Personnel , Humans , Medical History Taking , Practice Guidelines as Topic , Risk
4.
Eur J Paediatr Neurol ; 21(3): 580-582, 2017 May.
Article in English | MEDLINE | ID: mdl-28129950

ABSTRACT

BACKGROUND: A growing number of studies have disclosed the myriad of features that can suggest the diagnosis of a Glucose-transporter-1 deficiency (GLUT1D). The occurrence of paroxysmal movement disorders such as exercise-induced dystonia and non-kinesigenic dyskinesia, received considerable emphasis, while limited attention has been paid to other paroxysmal phenomena, as transitory neurological disorders. These paroxysmal events are roughly and variably described as limb weakness, hemiparesis or ataxia. Their EEG correlate has been never documented. CASE DESCRIPTION AND CONCLUSION: We report the EEG pattern characterizing two acute episodes of paroxysmal paresis with confusion and aphasia, in a girl with GLUT1D. The EEG picture is characterized by a clear-cut contralateral EEG slowing, similar to what is observed in Alternating Hemiplegia of Childhood and Hemiplegic Migraine attacks. In our patient the paroxysmal events were responsive to a ketogenic diet.


Subject(s)
Carbohydrate Metabolism, Inborn Errors/physiopathology , Monosaccharide Transport Proteins/deficiency , Paresis/physiopathology , Aphasia/complications , Carbohydrate Metabolism, Inborn Errors/complications , Carbohydrate Metabolism, Inborn Errors/diet therapy , Child , Confusion/complications , Diet, Ketogenic , Electroencephalography , Female , Humans , Paresis/complications , Paresis/diagnosis
6.
Hum Vaccin Immunother ; 11(12): 2800-5, 2015.
Article in English | MEDLINE | ID: mdl-26378476

ABSTRACT

It is debated whether patients with celiac disease (CD) have non-protective antibody responses to HBV vaccination more frequently than non-affected subjects. To perform a literature review and meta-analysis on protective response to HBV vaccination in CD patients. RCTs and observational controlled studies were eligible. Outcome of interest was an anti-HBs (HBsAb) titer ≥ 10 IU/L after last vaccine dose. Comparative index was rate ratio (RR). Heterogeneity between studies was addressed and funnel plots were analyzed. Meta-regression models were applied to investigate effect size due to study-specific variables. Twelve retrospective studies on a total of 1,447 participants and 4 prospective studies on 184 subjects were selected. The RR was 0.732 (95% C.I.: 0.664-0.808) and 0.777 (95% C.I.: 0.629-0.960) in the prospective and retrospective studies, respectively. The I(2), indicating heterogeneity, was 51.1% in retrospective, 39.8% in prospective studies. Non-protective antibody responses occurred more frequently in patients than controls. Due to limitations in the available studies, additional trials to evaluate post-vaccination HBsAb titer in CD patients are needed.


Subject(s)
Antibodies, Viral/blood , Celiac Disease/immunology , Hepatitis B Surface Antigens/immunology , Hepatitis B Vaccines/immunology , Vaccination/adverse effects , Antibodies, Viral/immunology , Hepatitis B/prevention & control , Hepatitis B Antibodies/immunology , Hepatitis B virus/immunology , Humans
SELECTION OF CITATIONS
SEARCH DETAIL
...